Presentation TCT 2025 TCT 1704: Vulnarable Plaque Passivation With Magnesium Resorbable Scaffold (Freesolve): Acute and One-year Multimodality Evaluation With OCT, IVUS NIRS and Radial Wall Strain Presenter: Stefano Galli October 28, 2025
News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025
Presentation TCT 2025 TCT 1257: Residual Lipid-Rich Plaque Features Identified by IVUS-NIRS in NSTE-ACS Patients Presenter: Tamara Natasha Dijkstra October 26, 2025
Presentation TCT 2025 TCT 1243: Multimodality Imaging in Acute MI (MIAMI Study): NIRS-IVUS and OCT of Vulnerable Plaques in Non-Infarct-Related Arteries in STEMI Patients Presenter: Samia Mazumder October 26, 2025
Presentation TCT 2025 TCT 1244: Inverse Association Between Body Mass Index and Coronary Plaque Vulnerability Assessed by NIRS-IVUS: : A Mechanistic Insight Into the Obesity Paradox Presenter: Woohyeun Kim October 26, 2025
Presentation TCT 2025 TCT 1241: Atherogenic Lipoproteins and Intraplaque Lipid Burden: Evidence from NIRS-IVUS in Statin-Naive Patients Presenter: Woohyeun Kim October 26, 2025
Presentation TCT 2025 TCT 687: Combined DeepOCT+NIRS Imaging for Coronary Stent Optimization: Results from the Investigational Study of SpectraWAVE’s HyperVue Imaging System Presenter: Evan Shlofmitz October 26, 2025
Presentation TCT 2025 TCT 412: Comprehensive Multimodal Assessment of Vulnerable Coronary Plaque Integrating Angiographic-Based Murray’s QFR, Radial Wall Strain (RWS), IVUS-NIRS and CCTA Presenter: Stefano Galli October 26, 2025
Presentation TCT 2024 TCT 520: Contemporary Trends and Practice Variation With Use of Intravascular Ultrasound During Peripheral Vascular Intervention Presenter: Frank Medina October 29, 2024
Presentation TCT 2024 TCT 518: First-in-Man Use of Continuous Thermodilution Derived FFR and Absolute Flow in Physiological Assessment of Peripheral Arterial Disease Presenter: Sarosh Khan October 29, 2024
Presentation TCT 2024 TCT 1020: A Preliminary Exploration of Dual-Frequency IVUS Imaging for the Assessment of Plaque Vulnerability Through Lipid and Fibrous Cap Characterization Presenter: Teng Ma October 29, 2024
Presentation TCT 2024 First-in-Human and Early Feasibility Studies with a Dual-Frequency IVUS Imaging System for the Assessment of Plaque Vulnerability Through Lipid and Fibrous Cap Characterization Presenter: Teng Ma October 29, 2024
Presentation TCT 2024 Augmented Hybrid NIRF-IVUS: A Groundbreaking Technology for Molecular Imaging of Coronary Artery Disease Presenter: Farouc Jaffer October 29, 2024
Presentation TCT 2024 TCT 529: Major Adverse Periprocedural Events Following Optical Coherence Tomographic Versus Intravascular Ultrasound-Guided Percutaneous Coronary Intervention Presenter: Sheriff Dodoo October 29, 2024
Presentation TCT 2024 TCT 528: Predictive Values of the Post-PCI OCT Findings for Target-Vessel Failure: Insights From the OCTIVUS Trial Presenter: Han Su Park October 29, 2024
Presentation TCT 2024 TCT 527: Sex Differences in Outcomes Following Optical Coherence Tomography and Intravascular Ultrasound-Guided PCI: A Subgroup Analysis of the OCTIVUS Trial Presenter: Soo Yeon An October 29, 2024
Presentation TCT 2024 TCT 526: Comparative Analysis of Optical Flow Ratio Derived From OCT Images and Ultrasonic Flow Ratio Derived From IVUS at Sequential Side Branches Within the Same Segment of the Coronary Vessel Presenter: Pruthvi C Revaiah October 29, 2024
Presentation TCT 2024 TCT 525: Mechanical Outcomes of Coronary Stenting Guided by Intravascular Ultrasound Versus Optical Coherence Tomography: An Updated Meta-Analysis of Randomized Trials Presenter: Mohamed Doma October 29, 2024
Presentation TCT 2024 TCT 524: Comparative Clinical Benefit of Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided PCI for True Bifurcation Lesions Presenter: Seong-Bong Wee October 29, 2024
Presentation TCT 2024 TCT 54: Intravascular Ultrasound-Guided Versus Angiography-Guided Percutaneous Coronary Intervention in Acute Coronary Syndromes (IVUS-ACS): A Two-Stage, Multicentre, Randomised Trial Presenter: NULL October 28, 2024